We encourage companies
that project change
t

t
@CaixaCR

N

News & events

MedLumics, a company owned by "la Caixa" and Ysios Capital, closes a financing round of 34.4 million euros

22.03.2017

• Medlumics has closed a round of financing round of 34,4 million euros to bring their main product into the market, AblaView, an atrial fibrillation treatment in the field of cardiac arrhythmias. • Medlumics is a company dedicated to medical technology for the treatment of cardiac diseases, with products based on photonic energy. • Caixa Capital Risc and Ysios Capital invested in Medlumics in 2012 to support the company in its development. • This has been the largest round in the history of the medical technology industry in Spain, and one of the largest in Europe.

Continue reading...

Other news See all news »